ACTION

Prime Minister strengthens ties with the French-speaking world at the Sommet de la Francophonie

Retrieved on: 
Domenica, Novembre 20, 2022
ASEAN, Cholera, President of the Swiss Confederation, Cyberattack during the Paris G20 Summit, Growth, ASEAN Summit, Face, Democracy, Climate change, Woman, Summit, Government, Environment, Empowerment, Corruption, G20, ACTION, Organization, APEC, Aggression, D-8 Organization for Economic Cooperation, Offense, Education, Research, 16 Days of Activism against Gender-based Violence, Sommets du cinéma d'animation, Cultural diversity, Food, Agence universitaire de la Francophonie, Indo-Pacific, Freezing, Premier of Quebec, Foreign Affairs, Violence, Language, Public relations, Agriculture, Animal, Drug, Organisation internationale de la Francophonie

At the Sommet de la Francophonie, Prime Minister Trudeau reaffirmed Canada's commitment to remaining a strong partner for fellow Francophonie members and governments and continuing to support La Francophonie's institutions.

Key Points: 
  • At the Sommet de la Francophonie, Prime Minister Trudeau reaffirmed Canada's commitment to remaining a strong partner for fellow Francophonie members and governments and continuing to support La Francophonie's institutions.
  • At the Summit, the Prime Minister reiterated Canada's commitment to promote democracy and human rights in Francophonie countries and around the world.
  • This is the third Sommet de la Francophonie attended by Prime Minister Trudeau.
  • This was the 18th Sommet de la Francophonie, and the first to be held in four years.

Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update

Retrieved on: 
Giovedì, Novembre 3, 2022
Company, Private Securities Litigation Reform Act, Exercise, Sale, Association, GLOBE, Probability, Neuro, FDA, Investor, Population, Safety, ACTION, Conference, Biomedical Advanced Research and Development Authority, HIV disease progression rates, Conference call, NDA, Research, U.S. Securities and Exchange Commission, Data, New Drug Application, Forward-looking statement, ID, Acceleration, Glioma, NASDAQ, Development, Human, Agency, Society, Emergent, Patient, BARDA, Pharmaceutical industry, Video game, Security (finance), ONC201

DURHAM, N.C., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today reported financial results for the third quarter ended September 30, 2022 and provided an operational update.

Key Points: 
  • In the meantime, we remain disciplined with spend across the organization as we complete the transition of TEMBEXAto Emergent.
  • Chimerix recorded a net loss of $18.6 million, or $0.21 per basic and diluted share, for the third quarter of 2021.
  • General and administrative expenses increased to $5.3 million for the third quarter of 2022, compared to $4.9 million for the same period in 2021.
  • Chimerix will host a conference call and live audio webcast to discuss third quarter 2022 financial results and provide a business update today at 8:30 a.m.

Alcoa Foundation celebrates 70-year legacy

Retrieved on: 
Martedì, Novembre 1, 2022
Professional Services, Machine Tools, Metalworking & Metallurgy, Philanthropy, Other Natural Resources, Mining, Minerals, Natural Resources, Other Manufacturing, Fund Raising, Steel, Foundation, Other Philanthropy, Environmental, Social and Governance (ESG), Manufacturing, Partnership, Organization, Research, Poverty, Program, Food, Workforce, Volta Aluminum Company, Homelessness, Education, ACTION, Foundation, History, Topical steroid withdrawal, Environment, Sustainability, Pharmaceutical industry, Aluminium, Tourism

This year Alcoa Foundation celebrates its 70th anniversary, heralding a legacy of giving that has benefitted non-profit organizations and Alcoa communities for seven decades.

Key Points: 
  • This year Alcoa Foundation celebrates its 70th anniversary, heralding a legacy of giving that has benefitted non-profit organizations and Alcoa communities for seven decades.
  • Alcoa Foundation was founded in 1952 with a $16.9 million endowment by the Aluminum Company of America (renamed Alcoa Inc. in 1999).
  • Following the legal separation of Alcoa into two standalone companies in 2016, the original Alcoa Foundation was divided, and a new Alcoa Foundation associated with Alcoa Corporation was launched.
  • Learn more about Alcoa Foundation at Alcoa Foundation and follow @AlcoaFoundation on Facebook and Twitter .

Latinas Rising Up In HR Launches Second Volume; Author Brings 15 More Stories of Latinas to the Executive Table

Retrieved on: 
Martedì, Ottobre 18, 2022
Statistics, Human resources, Government, University of Miami Patti and Allan Herbert Business School, Forbes, Organization, Dream, University, Partial, ACTION, Ownership, Drug, Management, Book, Volume Two, Hispanic and Latino Americans

MIAMI, Oct. 18, 2022 /PRNewswire-PRWeb/ -- Capturing the success and curiosity of "Latinas Rising Up In HR," author and Chicago-native, now Miami-based Human Resource Leader Priscilla Guasso recently launched "Latinas Rising Up In HR, Volume II" at the University of Miami's Herbert Business School in Storer Auditorium.

Key Points: 
  • Capturing the success and curiosity of "Latinas Rising Up In HR," author and Chicago-native, now Miami-based Human Resource Leader Priscilla Guasso recently launched "Latinas Rising Up In HR, Volume II" at the University of Miami's Herbert Business School in Storer Auditorium.
  • MIAMI, Oct. 18, 2022 /PRNewswire-PRWeb/ -- Capturing the success and curiosity of "Latinas Rising Up In HR," author and Chicago-native, now Miami-based Human Resource Leader Priscilla Guasso recently launched "Latinas Rising Up In HR, Volume II" at the University of Miami's Herbert Business School in Storer Auditorium.
  • The book presents inspirational stories of aspiring human resources professionals who boldly overcame obstacles and defied statistics to achieve their dreams in corporate America, nonprofit, government and as entrepreneurs.
  • Partial proceeds of this book will fund their student and professional-specific scholarships:
    The following corporate partners for this launch are:

Robbins Geller Rudman & Dowd LLP Announces Proposed Settlement in the Inovio Pharmaceuticals Settlement

Retrieved on: 
Martedì, Settembre 27, 2022
Class Action Lawsuit, Professional Services, Legal, Settlement, Claim, Class Action, THE, DO, CLASS, Hearing, Judgement, Federal Rules of Civil Procedure, OR, Client First Settlement Funding, AND, Allocation, List of United States federal courthouses, YOU, Leading Counsel, Court, Class, SET, District court, Market Street, ACTION, COMMON, Insurance, Cryptocurrency, Notice

IF YOU PURCHASED OR ACQUIRED INOVIO PHARMACEUTICALS, INC. (INOVIO) COMMON STOCK FROM FEBRUARY 14, 2020 THROUGH AUGUST 10, 2020, INCLUSIVE (THE CLASS), YOU COULD RECEIVE A PAYMENT FROM A CLASS ACTION SETTLEMENT.

Key Points: 
  • IF YOU PURCHASED OR ACQUIRED INOVIO PHARMACEUTICALS, INC. (INOVIO) COMMON STOCK FROM FEBRUARY 14, 2020 THROUGH AUGUST 10, 2020, INCLUSIVE (THE CLASS), YOU COULD RECEIVE A PAYMENT FROM A CLASS ACTION SETTLEMENT.
  • CERTAIN PERSONS ARE EXCLUDED FROM THE DEFINITION OF THE CLASS AS SET FORTH IN THE STIPULATION OF SETTLEMENT.
  • If you submit a written request for exclusion, you will have no right to recover money pursuant to the Settlement.
  • If you have any questions about the Settlement, or your eligibility to participate in the Settlement, you may contact Lead Counsel at the following address or by calling 1-800-449-4900:

Tessa Therapeutics Doses First Patient in Phase 1b Clinical Trial Investigating TT11 in Combination with Nivolumab for the Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)

Retrieved on: 
Mercoledì, Agosto 17, 2022
FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Phase II, European Medicines Agency, Trial of the century, ORR, GLOBE, Population, ASH, Private Securities Litigation Reform Act, Immunoglobulin G, Hematological Cancer Research Investment and Education Act, PD-1, Cancer, Marketing, Patient, Therapy, Company, TT11, Lymphatic system, Nivolumab, Safety, CTO, Disease, Hodgkin lymphoma, CD30, Progression-free survival, Toxic epidermal necrolysis, ACTION, CHL, Food, PRIME, Pharmaceutical industry, Vaccine

SINGAPORE, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the dosing of the first patient in a Phase 1b clinical trial investigating TT11, the company’s autologous CD30 chimeric antigen receptor T-cell (CAR-T) therapy, in combination with Bristol Myers Squibb’s nivolumab as a potential second-line treatment for patients with relapsed or refractory CD30-positive classical Hodgkin lymphoma (cHL).

Key Points: 
  • Patients will initially receive two cycles of nivolumab dosed at four-week intervals followed by lymphocyte depleting treatment with fludarabine/bendamustine chemotherapy.
  • Patients will then receive a single infusion of TT11, followed by two additional cycles of nivolumab.
  • Data from our ongoing clinical program investigating TT11 as a monotherapy treatment for later lines of classical Hodgkin lymphoma has demonstrated the CAR-T therapy to be safe with promising measures of efficacy.
  • Tessas lead clinical asset, TT11, is an autologous CD30-CAR-T therapy currently being investigated as a potential treatment for relapsed or refractory classical Hodgkin lymphoma as both a monotherapy (Phase 2) and combination therapy (Phase 1b).

Fresno City Council Members and Safety Advocates Come Together to Oppose Dangerously Flawed California SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Mercoledì, Agosto 10, 2022
Fresno City Council, Multimedia, City, Drinking, Public health, Centers for Disease Control and Prevention, SB, STOP, Policy, Sale, District, Los Angeles City Council District 5, Fresno City Hall, Fresno Police Department, CDC, Center, DUI, Alcohol Justice, Safety, Assembly, Council, ACTION, Public policy, NO, Democratic Party, Health, CHES, Nightclub, Cathedral city (disambiguation)

FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.

Key Points: 
  • FRESNO, Calif., Aug. 9, 2022 /PRNewswire/ -- Members of the Fresno City Council joined with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at Fresno City Hall Tuesday to condemn California SB 930.
  • The experiment would take place in 6 cities: San Francisco, Oakland, West Hollywood, Cathedral City, Coachella, and Palm Springs.
  • "The effort to keep Fresno bars open until 4 a.m. from 2 a.m. was reckless and dangerous,"said Fresno City Councilmember Gary Bredefeld.
  • That's why several Council colleagues and I are bringing forward a Council resolution on August 11th opposing this stupidity.

Assemblymember Tom Lackey Joins Health and Safety Advocates to Oppose SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Martedì, Agosto 9, 2022
Fresno City Council, City, Drinking, Public health, Centers for Disease Control and Prevention, SB, STOP, Los Angeles City Council District 3, CDC, Letter, Center, Alcohol Justice, CAPA, ACTION, Democratic Party, Nightclub

If the bill becomes law, all surrounding communities of pilot project cities will be threatened by late night drinkers traveling drunk and fatigued into the early morning commute hours.

Key Points: 
  • If the bill becomes law, all surrounding communities of pilot project cities will be threatened by late night drinkers traveling drunk and fatigued into the early morning commute hours.
  • According to the Center for Disease Control (CDC), California currently suffers more annual alcohol-related harm than any other state: 11,000 alcohol-related deaths, $35 billion in total costs, $18.5 billion in state costs.
  • Opposition to SB 930 is growing statewide.
  • Last week, the Los Angeles City Council passed a resolution of opposition , and the powerful Los Angeles County Democratic Party (LACDP) came out against SB 930 in a letter dated June 27, 2022.

Fresno City Council Members Join Health and Safety Advocates to Oppose SB 930 - the 4 a.m. Bar Bill

Retrieved on: 
Lunedì, Agosto 8, 2022
Fresno City Council, City, Drinking, Public health, Centers for Disease Control and Prevention, SB, STOP, Sale, Los Angeles City Council District 2, CDC, Letter, Center, Alcohol Justice, Safety, Assembly, ACTION, Democratic Party, Health, Nightclub, Cathedral city (disambiguation), Fresno City Hall

FRESNO, Calif., Aug. 8, 2022 /PRNewswire/ -- Members of the Fresno City Council will join with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at a Fresno City Hall press event to oppose California SB 930.

Key Points: 
  • FRESNO, Calif., Aug. 8, 2022 /PRNewswire/ -- Members of the Fresno City Council will join with health and safety advocates from Alcohol Justice and the Friday Night Live Partnership at a Fresno City Hall press event to oppose California SB 930.
  • SB 930 would allow closing times for on-sale retailers to be extended from 2 a.m. to 4 a.m. as part of a dangerous "pilot program."
  • The experiment would take place in 6 cities: San Francisco, Oakland, West Hollywood, Cathedral City, Coachella, and Palm Springs.
  • Where: Fresno City Hall 2600 Fresno Street, Media Room 2120 2nd floor.

Los Angeles City Council Votes NO on SB 930 - the 4 a.m. Bar Bill, Sends Strong Message to Sacramento and Senator Wiener that Public Safety is more Important than Nightlife Revenue

Retrieved on: 
Sabato, Agosto 6, 2022
City, Public health, Centers for Disease Control and Prevention, SB, Sale, Resolution, City council, Los Angeles City Council District 5, Restaurant, CDC, Letter, Center, Alcohol Justice, Council, Los Angeles City Council, CAPA, Town hall, ACTION, STOP, Democratic Party, Nightclub, Cathedral city (disambiguation), L.A

SB 930 would allow closing times for on-sale retailers to be extended from 2 a.m. to 4 a.m. as part of a dangerous "pilot program."

Key Points: 
  • SB 930 would allow closing times for on-sale retailers to be extended from 2 a.m. to 4 a.m. as part of a dangerous "pilot program."
  • The experiment would take place in 6 cities: San Francisco, Oakland, West Hollywood, Cathedral City, Coachella, and Palm Springs.
  • In Los Angeles, the powerful Los Angeles County Democratic Party (LACDP) came out against SB 930 in a letter made public before a City Hall opposition rally last week.
  • Alcohol Justice encourages the public to TAKE ACTION to STOP SB 930: Text JUSTICE to 313131 or visit: https://alcoholjustice.org/take-action/stop-sb-930-no-late-last-calls-in...